Municipal Employees Retirement System of Michigan continued to hold its stake in Halyard Health, Inc. (NYSE:HYH) during the first quarter, Holdings Channel reports. The institutional investor owned 21,500 shares of the medical instruments supplier’s stock at the end of the first quarter. Municipal Employees Retirement System of Michigan’s holdings in Halyard Health were worth $819,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. CENTRAL TRUST Co increased its stake in Halyard Health by 1.0% in the first quarter. CENTRAL TRUST Co now owns 2,643 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 25 shares in the last quarter. Meadow Creek Investment Management LLC increased its stake in Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 28 shares in the last quarter. Glen Harbor Capital Management LLC increased its stake in Halyard Health by 1.1% in the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock worth $123,000 after buying an additional 34 shares in the last quarter. Victory Capital Management Inc. bought a new stake in Halyard Health during the first quarter worth about $153,000. Finally, Capstone Asset Management Co. bought a new stake in Halyard Health during the first quarter worth about $203,000. 91.87% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Halyard Health, Inc. (HYH) traded down 0.59% during mid-day trading on Friday, hitting $38.61. 578,072 shares of the stock were exchanged. Halyard Health, Inc. has a 52 week low of $30.88 and a 52 week high of $41.84. The company has a 50-day moving average of $37.22 and a 200-day moving average of $38.26. The stock has a market capitalization of $1.80 billion, a PE ratio of 47.03 and a beta of 1.79.

Halyard Health (NYSE:HYH) last released its earnings results on Tuesday, May 2nd. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The firm had revenue of $395.60 million during the quarter, compared to analyst estimates of $391.56 million. Halyard Health had a net margin of 2.40% and a return on equity of 8.16%. The business’s revenue was up 2.8% on a year-over-year basis. During the same quarter last year, the business earned $0.53 EPS. On average, equities analysts predict that Halyard Health, Inc. will post $1.85 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Municipal Employees Retirement System of Michigan Has $819,000 Position in Halyard Health, Inc. (HYH)” was originally posted by Financial Market News and is the property of of Financial Market News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.financial-market-news.com/2017/06/17/municipal-employees-retirement-system-of-michigan-has-819000-position-in-halyard-health-inc-hyh.html.

HYH has been the subject of a number of research analyst reports. TheStreet raised shares of Halyard Health from a “c” rating to a “b-” rating in a report on Thursday, April 6th. Zacks Investment Research raised shares of Halyard Health from a “sell” rating to a “buy” rating and set a $44.00 price objective for the company in a report on Wednesday, May 3rd. Stifel Nicolaus lifted their price objective on shares of Halyard Health from $38.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, February 28th. Finally, Stephens downgraded shares of Halyard Health from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 28th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Halyard Health presently has a consensus rating of “Hold” and a consensus target price of $40.50.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.